Literature DB >> 17917713

Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver.

Andreas Umgelter, Wolfgang Reindl, Roland M Schmid, Wolfgang Huber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17917713     DOI： 10.1007/s00134-007-0877-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

2.  Continuous terlipressin infusion in patients with septic shock: less may be best, and the earlier the better?

Authors:  Andrea Morelli; Christian Ertmer; Matthias Lange; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-05-25       Impact factor: 17.440

3.  Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome.

Authors:  R Moreau; A Hadengue; T Soupison; P Kirstetter; M F Mamzer; D Vanjak; P Vauquelin; M Assous; C Sicot
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

4.  [Effects of glypressin on the splanchnic and systemic circulation in patients with cirrhosis].

Authors:  D Valla; S S Lee; R Moreau; A Hadengue; R Sayegh; D Lebrec
Journal:  Gastroenterol Clin Biol       Date:  1985-12

Review 5.  Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

Authors:  R W Schrier; V Arroyo; M Bernardi; M Epstein; J H Henriksen; J Rodés
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425
  5 in total
  6 in total

1.  Acute esophageal variceal bleeding: Current strategies and new perspectives.

Authors:  Salvador Augustin; Antonio González; Joan Genescà
Journal:  World J Hepatol       Date:  2010-07-27

2.  Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.

Authors:  Andrea Morelli; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Valeria Cecchini; Alessandra Bachetoni; Mariadomenica D'Alessandro; Hugo Van Aken; Paolo Pietropaoli; Martin Westphal
Journal:  Crit Care       Date:  2009-08-10       Impact factor: 9.097

3.  Current place of vasopressin analogues in the treatment of septic shock.

Authors:  Christian Ertmer; Sebastian Rehberg; Andrea Morelli; Martin Westphal
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

4.  The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.

Authors:  Ken Ishikawa; Li Wan; Paolo Calzavacca; Rinaldo Bellomo; Michael Bailey; Clive N May
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

5.  Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort.

Authors:  Lukasz A Myc; Jonathan G Stine; Rinita Chakrapani; Alexandra Kadl; Curtis K Argo
Journal:  World J Hepatol       Date:  2017-01-18

6.  Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial.

Authors:  Magdy Mohammed Mahdy; Mostafa Samy Abbas; Emad Zarief Kamel; Mohamed Fathy Mostafa; Ragaa Herdan; Shimaa Abbas Hassan; Ramy Hassan; Ahmed M Taha; Tameem M Ibraheem; Bashir A Fadel; Mohammed Geddawy; Jehan Ahmed Sayed; Osama Ali Ibraheim
Journal:  BMC Anesthesiol       Date:  2019-06-15       Impact factor: 2.217
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.